GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neola Medical AB (OSTO:NEOLA) » Definitions » Operating Income

Neola Medical AB (OSTO:NEOLA) Operating Income : kr-9.84 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Neola Medical AB Operating Income?

Neola Medical AB's Operating Income for the three months ended in Mar. 2024 was kr-2.57 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was kr-9.84 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Neola Medical AB's Operating Income for the three months ended in Mar. 2024 was kr-2.57 Mil. Neola Medical AB's Revenue for the three months ended in Mar. 2024 was kr0.00 Mil. Therefore, Neola Medical AB's Operating Margin % for the quarter that ended in Mar. 2024 was %.

Neola Medical AB's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Neola Medical AB's annualized ROC % for the quarter that ended in Mar. 2024 was -18.03%. Neola Medical AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -8,117.00%.


Neola Medical AB Operating Income Historical Data

The historical data trend for Neola Medical AB's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neola Medical AB Operating Income Chart

Neola Medical AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
Get a 7-Day Free Trial -2.62 -6.72 -6.65 -10.39 -9.63

Neola Medical AB Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.36 -2.59 -2.54 -2.15 -2.57

Neola Medical AB Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neola Medical AB  (OSTO:NEOLA) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Neola Medical AB's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-10.268 * ( 1 - 0% )/( (61.9 + 52.006)/ 2 )
=-10.268/56.953
=-18.03 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Neola Medical AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-10.268/( ( (0.137 + max(-5.527, 0)) + (0.116 + max(-4.077, 0)) )/ 2 )
=-10.268/( ( 0.137 + 0.116 )/ 2 )
=-10.268/0.1265
=-8,117.00 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.63) - (2.54 + 0 + 3.617)
=-5.527

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.805 + 0 + 0) - (0 + 0 + 5.882)
=-4.077

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Neola Medical AB's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-2.567/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Neola Medical AB Operating Income Related Terms

Thank you for viewing the detailed overview of Neola Medical AB's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Neola Medical AB (OSTO:NEOLA) Business Description

Traded in Other Exchanges
N/A
Address
Scheelevägen 27, Ideon Science Park, Lund, SWE, 223 63
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.

Neola Medical AB (OSTO:NEOLA) Headlines

No Headlines